Our study not only provides valuable mechanistic insights into the role of Trem2 in the AKI–CKD transition but also offers a new avenue for TREM2‐overexpressing macrophage‐based adoptive cell therapy to treat kidney diseases. This evidence concerns the gene TREM2 and chronic kidney disease.